Skip to content

Clinical trials

Observational Ureteral Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ureteral Neoplasms Phase: Observational Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20131
20161
20171
20191
20213
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed3
Active, not recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Changhai Hospital3
Yonsei University2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Fox Chase Cancer Center1
Guardant Health, Inc.1
Memorial Sloan Kettering Cancer Center1
Peking University First Hospital1
Taproot Health1
University of California, Davis1
University of Nebraska1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ureteral Neoplasms13
Urinary Bladder Neoplasms9
Carcinoma, Renal Cell5
Carcinoma, Transitional Cell5
Prostatic Neoplasms5
Colonic Neoplasms3
Esophageal Neoplasms3
Kidney Neoplasms3
Melanoma3
Rectal Neoplasms3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.